Skip to content
Disclosery

EXANE DERIVATIVES: DB position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on DB, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 121 DB shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 121 shares
    Change vs previous 13F -967 shares

    <0.01% of the 13F portfolio, value $1,045.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,088 shares
    Change vs previous 13F -42,537 shares

    <0.01% of the 13F portfolio, value $13,902.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 43,625 shares
    Change vs previous 13F +43,625 shares

    0.13% of the 13F portfolio, value $544,425.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-06-30
    13F 0 shares
    Change vs previous 13F -314,490 shares

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  5. period ended2021-03-31
    13F 314,490 shares
    Change vs previous 13F -42,534 shares

    1.13% of the 13F portfolio, value $3,757,001.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2020-12-31
    13F 357,024 shares
    Change vs previous 13F -47,176 shares

    1.19% of the 13F portfolio, value $3,919,886.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-09-30
    13F/A 404,200 shares
    Change vs previous 13F not available

    1.11% of the 13F portfolio, value $3,402,070.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).